To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Clinical trial NCT01900249 · COMPLETED
Trial details
- NCT number
- NCT01900249
- Sponsor
- Rigel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-07-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.